PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cuajLink to Publisher's site
 
Can Urol Assoc J. 2010 October; 4(5 Suppl 2): S102–S109.
PMCID: PMC2950753

Northeastern Section AUA 62nd Annual Meeting • Pittsburgh, PA • September 22–26, 2010

Thursday, September 23, 2010

7:30 a.m.Opening Session
Joel B. Nelson, Northeastern Section President
Datta G. Wagle, American Urological Association President
7:45 – 8:30 a.m.Plenary I: Dermatologic Conditions
Joseph English, University of Pittsburgh Medical Center, Pittsburgh, PA
8:30 – 8:45 a.m.PSA Update:
Datta Wagle, Buffalo, NY
8:45 – 9:30 a.m.Plenary II: AUA Practice Guidelines: The Workings and The Highlights
J. Stuart Wolf, University of Michigan, Ann Arbor, MI
9:30 – 9:45 a.m.Residents Debate
Topic: The Management of Upper Tract Urothelial Cancer
9:45 – 10:15 a.m.Break
10:15 – 10:30 a.m.AUA Committee on Male Health Update
P. Miller Ashman, Rochester, NY
10:30 – 10:50 a.m.Health Policy Update US and Canadian Perspective US Perspective – Ronald Kaufman
Canadian Perspective – Darrel Drachenberg
10:50 a.m. – NoonThe Section Session: What’s New in Female Urology
Elise De, University of Pittsburgh Medical Center, Pittsburgh, PA
Stephen Steele, Queens University, Kingston General Hospital, Kingston, ON, Canada
Wendy Leng, University of Pittsburgh Medical Center, Pittsburgh, PA
Sender Herschorn, Sunnybrook Health Sciences Center, Toronto, ON, Canada
Moderator: Elise De
Noon – 1:30 p.m.Sneak-peek Luncheon in Exhibit Hall
1:30 – 2:30 p.m.Plenary III: Medical Expulsive Therapy for Kidney Stones
Stephen Nakada, University of Wisconsin School of Medicine and Public Health, Madison, WI
2:30 – 2:45 p.m.Residents Debate
Topic: The Management of Kidney Stones in the Morbidly Obese
2:45 – 3:15 p.m.Break in Exhibit Hall
3:15 – 5 p.m.Concurrent Poster Sessions I & II
4 – 5 p.m.Moderated Poster Session I: Basic Science
Moderators: J. Stuart Wolf, JodiMaranchie
4 p.m.P1.Development of a Nanolantern™ Assay for Rapid Detection Of Enterobacter Cloaca.
Angelo J. Cambio1, Jennifer G. Rothschild1, Hsin-P Peng2, Robert D. Mayer1, Benjamin L. Miller2.
1University of Rochester Medical Center, Rochester, NY, USA; 2University of Rochester, Rochester, NY, USA.
4:03 p.m.P2.WITHDRAWN
4:06 p.m.P3.Nox4 Inhibitor as a Potential Therapeutic Agent for Renal Cell Carcinoma.
Li Chen, Guimin Chang, Jodi K. Maranchie. University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
4:09 p.m.P4.A Dual Adenoviral Amplification System Based on PSA-promoter to Increase Sensitivity of Detection of Prostate Cancer Cells in Vivo by Non-invasive Imaging.
Frederic Pouliot1, Makoto Sato2, Lily Wu2.
1Laval University, Quebec, QC, Canada; 2University of California, Los Angeles, Los Angeles, CA, USA.
4:12 p.m.P5.Increased Cancer Cell Proliferation in Prostate Cancer Patients with High Levels of Serum Folate.
Jeffrey J. Tomaszewski, Jessica L. Cummings, Anil Parwani, Rajiv Dhir, Joel B. Mason, Joel B. Nelson, Dean J. Bacich, Denise S. O’Keefe.
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
4:15 p.m.P6.Nitric Oxide Signaling Mediates Hypoxic Upregulation of Macrophage Inhibitory Factor in Prostate Cancer.
D. Robert Siemens.
Queen’s University, Kingston, ON, Canada.
4:18 p.m.P7.Reconstruction of a Human Vesical Equivalent Using Adipose-Derived Stem Cells.
Alexandre Rousseau, Jonathan Cloutier, Geneviève Bernard, Guillaume Marceau Fortier, Robert Gauvin, Sara Bouhout, Julie Fradette, Stéphane Bolduc.
LOEX, Centre de recherche FRSQ du CHA universitaire de Québec, Université Laval, Québec, QC, Canada.
4:21 p.m.P8.Stray Electrical Currents in Laparoscopic Instruments Used in DaVinci Robotic Surgery.
Carlos E. Mendez Probst1, George Vilos1, Paul Borg2, David Galloway2, Stephen E. Pautler1.
1Schulich School of Medicine and Dentistry, The University of Western Ontario, London, ON, Canada; 2St Joseph’s Health Care London, London, ON, Canada.
4:24 p.m.P9.Vitamin D3 Therapy Increases Cryoablation Efficacy: A Novel Strategy for the Treatment of Prostate Cancer.
John M. Baust, PhD1, Daniel Klossner, Anthony Robilotto1, Robert Van Buskirk1, Andrew Gage1, Vladimir Mouraviev3, Thomas Polascik3, John G. Baust2.
1CPSI Biotech, Owego, NY, USA; 2Binghamton University, Binghamton, NY, USA; 3Duke University Medical Center, Durham, NC, USA.
4:27 p.m.P10.Rapid Induction of Apoptosis at Ultra Low Temperatures Enhances the Efficacy of Prostate Cancer Cryoablation.
Anthony Robilotto, John M. Baust1, Robert VanBuskirk1, Andrew Gage1, John G. Baust2.
1CPSI Biotech, Owego, NY, USA; 2Binghamton University, Binghamton, NY, USA.
4:30 p.m.P11.The VHL Tumor Suppressor Promotes Renal Cancer Cell Apoptosis by Inhibiting Casein Kinase 2 Activity and Impairing NF- B Signaling.
Guan Wu, Xiangrong He, Edward M. Messing.
University of Rochester, Rochester, NY, USA.
4:33 p.m.P12.The Effect of Dietary Folate on Prostate Carcinogenesis in an in Vivo Model of Tumorigenesis.
Jeffrey J. Tomaszewski, Jessica L. Cummings, Anil Parwani, Dean J. Bacich, Denise S. O’Keefe.
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
4:36 p.m.P13.Nox4 is Required for Nuclear Translocation of HIF-2 in Renal Cancer Cells.
Guimin Chang, PhD, Li Chen, PhD, Jodi K. Maranchie
University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
4:39 p.m.P14.Temporal RF-Ultrasound Augmentation Of Prostate (TRAP): Enhancing Prostate Cancer
Detection Utilizing Temporal Ultrasound Radio Frequency Signals.
D. Robert Siemens, Purang Abolmaesumi, Parvin Mousavi, Mehdi Moradi, Eric Sauerbrei, Sandy Boag.
Queen’s University, Kingston, ON, Canada.
4:42 p.m.P15.Urinary MicroRNA as an Accurate Urinary Diagnostic Marker for Urothelial Cancer.
D. Robert Siemens, Jaime Snowden, Jason Izard, Sandy Boag, Harriet Feilotter.
Queen’s University, Kingston, ON, Canada.
4:45 p.m.P16.Development of a Realtime Intraoperative Electrical Impedance Tomography Sensor for Cavernous Nerve Mapping for Radical Prostatectomy.
Henry H. Tran, University of British Columbia, New Westminster, BC, Canada.
4:48 p.m.P17.Mapping the Cytokine Profile of Interstitial Cystitis in Human Bladder and Urine Specimens: A Pilot Study.
Anthony T. Corcoran1, Vikas Tyagi1, Masa Kita1, Pradeep Tyagi2, Wendy W. Leng1, Naoki Yoshimura1.
1University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 2William Beaumont Hospital, Royal Oak, MI, USA.
4:51 p.m.P18.Targeted Modulation of Integrin Expression Increases Freeze Sensitivity of Androgen-Insensitive Prostate Cancer.
John M. Baust1, Daniel Klossner2, Robert VanBuskirk1, Andrew Gage1, Vladimir Mouraviev3, Thomas Polascik3, John G. Baust4.
1CPSI Biotech, Owego, NY, USA; 2Binghamton University, Binghamton, NY, USA; 3Duke University Medical Center, Durham, NC, USA; 4Binghamton University, Binghamton, NY, USA.
4:54 p.m.Discussion
5 p.m.Adjourn
4 – 5 p.m.Moderated Poster Session II: Kidney Cancer
Moderators: Stephen Nakada, Neil Fleshner
4 p.m.P19.Synchronous Presence of Renal Pelvic And Ureteral Tumors Is Independently Prognostic of Survival Following Radical Nephrectomy.
Faysal A. Yafi1, Shahrokh Shariat2, Giacomo Novara3, Amit Gupta2, Kazumasa Matsumoto4, Thomas J. Walton5, Hans-Martin Fritsche6, Patrick J. Bastian7, Juan I. Martínez-Salamanca8, Christian Seitz9, Vincenzo Ficarra3, Pierre I. Karakiewicz10, Wassim Kassouf1.
1McGill University, Montreal, QC, Canada; 2University of Texas Southwestern Medical Center, Dallas, TX, USA; 3University of Padua, Padua, Italy; 4Kitasato University School of Medicine, Sagamihara, Japan; 5Derby City General Hospital, Derby, United Kingdom; 6Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; 7Ludwig-Maximilians-University, Klinikum Grosshadern, Munich, Germany; 8Hospital Universitario Puerta de Hierro-Majadahonda, Universidad Autónoma de Madrid, Madrid, Spain; 9General Hospital Bolzano, Bolzano, Italy; 10University of Montreal, Montreal, QC, Canada.
4:03 p.m.P20.Renal Cell Carcinoma in the Elderly: Is Partial Nephrectomy the Right Surgical Option?
Matthew H. Hayn1, Nicholas J. Hellenthal1, Rebecca O’Malley1, Hyung Kim2, Willie Underwood1,Thomas Schwaab1.
1Roswell Park Cancer Institute, Buffalo, NY, USA; 2Cedars-Sinai Medical Center, Los Angeles, CA, USA.
4:06 p.m.P21.Laparoscopic Partial Nephrectomy Guided by Near Infrared Fluorescence (NIRF) of Intravenous Indocyanine Green (ICG).
Joy K. Knopf, Scott Tobis, Guan Wu, Hani Rashid, Christopher R. Silvers, Jonah Marshall, Jorge Yao, Edward M. Messing, Dragan J. Golijanin.
University of Rochester, Rochester, NY, USA.
4:09 p.m.P22.Small Renal Mass Needle Biopsy: Outcomes of Non-Diagnostic Percutaneous Biopsy and Rate of Repeat Biopsy.
Michael Jewett1, Michael Leveridge2, John R. Kachura2, Andrew J. Evans2, Antonio Finelli2.
1University of Toronto, Toronto, ON, Canada, 2Princess Margaret Hospital, Toronto, ON, Canada.
4:12 p.m.P23.Patterns of Non-surgical Management of Small Renal Masses: A Population-based Analysis.
Rupinder Johal1, Firas Abdollah1, Lars Budaus2, Rodolphe Thuret3, Maxine Sun1, Monica Morgan1, Daniel Liberman1, Giovanni Lughezzani4, Claudio Jeldres1, Al’a Abdo1, Salima Ismail1, Shahrokh F. Shariat1, Paul Perrotte5, Francesco Montorsi4, Markus Graefen6, Pierre I. Karakiewicz1.
1Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC, Canada; 2Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 3Urology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France; 4Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; 5Department of Urology, University of Montreal Health Center, Montreal, QC, Canada; 6Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
4:15 p.m.P24.A Population-based Analysis of Perioperative Complications and Mortality Associated with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.
Rupinder Johal1, Giovanni Lughezzani2, Lars Budaus3, Rodolphe Thuret4, Firas Abdollah1, Maxine Sun1, Monica Morgan1, Daniel Liberman1, Salima Ismail1, Al’a Abdo1, Markus Graefen5, Paul Perrotte6, Shahrokh F. Shariat1, Francesco Montorsi2, Pierre I. Karakiewicz1.
1Cancer Prognosis and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada; 2Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; 3Department of Urology, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany; 4Department of Urology, Montpellier University Hospital, Montpellier, France; 5Department of Urology, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany; 6Department of Urology, University of Montreal, Montreal, QC, Canada.
4:18 p.m.P25.Percutaneous Radiofrequency Ablation of Small Renal Tumors: McGill University Initial Experience.
Nader Fahmy, Tatiana Cabrera, David Valenti, Maurice Anidjar.
McGill University, Montreal, QC, Canada.
4:21 p.m.P26.Renal Cell Carcinoma in Octogenarians: Comprehensive Analysis Using the Seer Database.
Matthew Hayn, Nicholas J. Hellenthal, Willie Underwood, Thomas Schwaab.
Roswell Park Cancer Institute, Buffalo, NY, USA.
4:24 p.m.P27.Utilization Rates of Open Partial Nephrectomy and Laparoscopic Radical Nephrectomy in Patients with Nonmetastatic Renal Cell Carcinoma.
Monica Morgan1, Daniel Liberman1, Rupinder Johal1, Maxine Sun2, Salima Ismail1, Lars Budaus1, Giovanni Lughezzani3, Firas Abdollah2, Shahrokh F. Shariat2, Markus Graefen4, Paul Perrotte2, Pierre I. Karakiewicz2.
1University of Montreal Health Centre, Montreal, QC, Canada; 2Cancer Prognostics and Health Outcomes Unit, Montreal, QC, Canada; 3Vita-Salute University San Raffaele, Milan, Italy; 4Martiniclinic, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
4:27 p.m.P28.A Population-based Analysis of the Perioperative Outcomes of Open Partial Versus Open Radical Nephrectomy.
Rupinder Johal1, Claudio Jeldres1, Giovanni Lughezzani2, Rodolphe Thuret3, Lars Budaus4, Maxine Sun1, Firas Abdollah1, Monica Morgan1, Daniel Liberman1, Salima Ismail1, Al’a Abdo1, Shahrokh F. Shariat1, Markus Graefen4, Paul Perrotte1, Pierre I. Karakiewicz1.
1Department of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada; 2Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; 3Urology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France; 4Prostate Cancer Centre, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
4:30 p.m.P29.The Rates of Metastatic Renal Cell Carcinoma are Decreasing Over Time: A Population-based Analysis.
Monica Morgan1, Rupinder Johal,1, Maxine Sun, BSc2, Daniel Liberman1, Ala Abdo1, Lars Budaus3, Rodolphe Thuret2, Salima Ismail1, Paul Perrotte2, Pierre I. Karakiewicz2.
1University of Montreal Health Centre, Montreal, QC, Canada; 2Cancer Prognostics and Health Outcomes Unit, Montreal, QC, Canada; 3Martiniclinic, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
4:33 p.m.P30.Percutaneous Ablation of Renal Masses: The Albany Medical Center Experience.
Michael A. Feuerstein, Badar M. Mian, Hugh Fisher, Ronald Kaufman Jr.
Albany Medical College, Albany, NY, USA.
4:36 p.m.P31.Advanced Techniques in Renal Radiofrequency Ablation.
Scott Tobis, Devang Butani, Wael Saad, Nikhil Patel, Erdal Erturk.
University of Rochester Medical Center, Rochester, NY, USA.
4:39 p.m.P32.Selective Arterial Embolizations (SAE) of Renal Angiomyolipomas (AML): A Single Institution Experience.
Scott Tobis, Joy Knopf, David Waldman, Edward Messing, Erdal Erturk, Dragan Golijanin.
University of Rochester Medical Center, Rochester, NY, USA.
4:42 p.m.P33.Predictors of Health-Related Quality of Life Recovery Following Laparoscopic Simple, Radical and Donor Nephrectomy.
Joshua D. Wiesenthal, Trevor Schuler, R. John D’A. Honey, Kenneth T. Pace.
University of Toronto, Toronto, ON, Canada.
4:45 p.m.P34.Transumbilical Laparoendoscopic Single-Site (U-LESS) Nephrectomy: Initial Experience of 16 Cases.
Guan Wu, Jonah Marshall, Scott Tobis, Dragan J. Golijanin, Hani Rashid.
University of Rochester, Rochester, NY, USA.
4:48 p.m.Discussion
5 p.m.Adjourn
5 – 6 p.m.Industry-sponsored Symposium
6 – 7 p.m.Exhibit Hall Grand Opening/Welcome Reception

Friday, September 24, 2010

7 – 8 a.m.5K Run/Walk
7:30 – 7:45 a.m.Best-of-Poster Sessions
Presented by moderators of previous day’s poster sessions
7:45 – 8:45 a.m.Plenary IV: Section Stars (Prize-Winning Essays & Past NS Scholars)
8:45 – 9:30 a.m.Plenary V
Urology Education and Simulation
Elspeth McDougall, UCI Medical Center, Orange, CA
9:30 – 9:45 a.m.Residents Debate
Topic: The Management of a Large Kidney Stone
9:45 – 10:15 a.m.Break in Exhibit Hall
10:15 - NoonConcurrent Poster Sessions III & IV
11 a.m. – NoonModerated Poster Session III: Assorted Urology Topics
Moderators: Elspeth McDougall, Kenneth Pace
11 a.m.P35.Percutaneous Nephrolithotomy in the Prone-Flexed Position: Is There an Optimal Access?
R. John D’A. Honey, Joshua D. Wiesenthal, Daniela Ghiculete, Steven Pace, Kenneth T. Pace.
University of Toronto, Toronto, ON, Canada.
11:03 a.m.P36.Effective Radiation Exposure in Follow up of Patients
with Nephrolithiasis.
Nader Fahmy, Sero Andonian.
McGill University, Montreal, QC, Canada.
11:06 a.m.P37.Predictors of Outcome of Percutaneous Nephrolithotomy.
Khaled Shahrour, Jeffrey Tomaszewski, Tara Ortiz, Kevan Sternberg, Li Wang, Marc Smaldone, Stephen Jackman, Timothy Averch.
University of Pittsburgh, Pittsburgh, PA, USA.
11:09 a.m.P38.Single Institution Review of the Incidence of Perinephric Hematoma after Shock Wave Lithotripsy.
Rasmus Leistner, Carlos E. Mendez-Probst, Linda Nott, RN, Petar Erdeljan, Sumit Dave, Hassan Razvi.
Schulich School of Medicine and Dentistry, The University of Western Ontario, London, ON, Canada.
11:12 a.m.P39.Intermediate-sized Urolithiasis: The Equivalency of Treatment Modalities.
Joshua D. Wiesenthal, Daniela Ghiculet, R. John D’A Honey, Kenneth T. Pace.
University of Toronto, Toronto, ON, Canada.
11:15 a.m.P40.Ambulatory Percutaneous Nephrolithotomy: Initial Series.
Walid Shahrour, Sero Andonian.
McGill University, Montreal, QC, Canada.
11:18 a.m.P41.Radiation Exposure during Percutaneous Nephrolithotomy in a Contemporary Series.
Walid Shahrour, Sero Andonian, Konrad Szymanski.
McGill University, Montreal, QC, Canada.
11:21 a.m.P42.Tibial Nerve Neuromodulation of Bladder Activity in Cats.
Mang L. Chen1, Bing Shen2, Jicheng Wang1, Hailong Liu1, James Roppolo2, William de Groat2, Changfeng Tai1.
1University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 2University of Pittsburgh Dept of Pharmacology, Pittsburgh, PA, USA.
11:24 a.m.P43.WITHDRAWN
11:27 a.m.P44.Standard of Care Outcomes Using Mesh Products (“Perigee” and “Apogee”) for Treating Female Pelvic Prolapse in 170 Patients — Single Surgeon Experience.
Erin Bowser, DO1, Ratna Ganabathi2, Kumaresan Ganabathi1.
1Clarion Hospital, Clarion, PA, USA, 2Lake Erie Osteopathic College of Medicine, Erie, PA, USA.
11:30 a.m.P45.Pelvic Floor Reconstruction with Customized Mesh.
Kenneth K. Hu, Julian Tolentino, Marydonna Ravasio, John Glaser, Aaron Schlott.
Butler Memorial Hospital, Butler, PA, USA.
11:33 a.m.P46.A Trial of Bilateral Percutaneous Nephrostomy Tube Placement in Refractory Non-ulcerative Interstitial Cystitis Patients Prior to Simple Urinary Diversion.
Mini Varghese, Robert D. Mayer.
University of Rochester, Rochester, NY, USA.
11:36 a.m.P47.Modified Scrotal (Bianchi) Mid-raphe Single-Incision Orchidopexy for Palpable Undescended Testis.
Jonathan Cloutier, Katherine Moore, Vincent Fradet, Stéphane Bolduc.
Laval University, Québec, QC, Canada.
11:39 a.m.P48.Renal Perfusion Pump vs. Cold Storage for Donation after Cardiac Death Kidneys: A Systematic Review.
Thomas B. McGregor, Varunkumar Bathini, Vivian McAlister, Patrick Luke, Alp Sener.
University of Western Ontario, London, ON, Canada.
11:42 a.m.Discussion
NoonAdjourn
11 a.m. – NoonModerated Poster Session IV: Prostate and Testes Cancer
Moderators: Dragan Goliganin, Gabriel Haas
11 a.m.P49.Aggressive Urologic Malignancy in Heart Transplant Recipients.
Abhijith D. Mally, Bruce L. Jacobs, Jeffrey Tomaszewski, Jeffrey Teuteberg, Yoshiya Toyoda, Diana Zaldonis, Stephen V. Jackman.
University of Pittsburgh, Pittsburgh, PA, USA.
11:03 a.m.P50.Risk of Secondary Malignancy in Patients with Testicular Cancer is Increased with Radiotherapy.
Dan Lewinshtein, Christopher Porter
Virginia Mason Medical Center, Seattle, WA, USA.
11:06 a.m.P51.Stage-Specific Population-based Trends of RPLND Use.
Daniel Liberman1, Lars Badaus2, Giovanni Lughezzani3, Ala Abdo1, Maxine Sun1, Monica Morgan1, Rodolphe Thuret4, Salima Ismail1, Wassim Kassouf5, Hugues Widmer1, Francesco Montorsi3, Paul Perrotte1, Shahrokh F. Shariat1, Pierre I. Karakiewicz1.
1University of Montreal Health Center, Montreal, QC, Canada; 2Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany; 3Vita-Salute San Raffaele, Milan, Italy; 4Centre Hospitalier Universitaire de Montpellier, Montpellier, France, 5McGill University, Montreal, QC, Canada.
11:09 a.m.P52.Decreased Survival of Black Americans with Testicular Cancer: A Contemporary Population-based Analysis.
Daniel Liberman,1Lars Badaus2, Monica Morgan1, Rupinder Johal1, Maxine Sun1, Ala Abdo1, Giovanni Lughezzani3, Rodolphe Thuret4, Wassim Kassouf5, Hugues Widmer1, Francesco Montorsi3, Shahrokh F. Shariat1, Paul Perrotte1, Pierre I. Karakiewicz1.
1University of Montreal Health Center, Montreal, QC, Canada; 2Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany; 3Vita-Salute San Raffaele, Milan, Italy; 4Centre Hospitalier Universitaire de Montpellier, Montpellier, France; 5McGill University, Montreal, QC, Canada.
11:12 a.m.P53.Toremifene 80 mg Demonstrates Reduction in Fracture Risk in Men Who are Less than 80 Years of Age on Androgen Deprivation Therapy.
Philip J. Aliotta1, Ronald Kaufman2, Michael Brawer3, Ronald A. Morton4, Mark D. Chazen1, John V. Pinski1.
1Main Urology Associates P.C., Buffalo, NY, USA; 2Community Care, Alband, NY, USA; 3GTx, Inc., Memphis, TN, USA; 4GTx, Inc, Memphis, TN, USA.
11:15 a.m.P54.Effect of Posterior Reconstruction of the Rhabdosphincter on Early Postoperative
Continence Following Robotic-assisted Radical Prostatectomy: A Comparison of Two Matched Groups.
Ahmed Ghazi, Granville Lloyd, Mathew Lux, Hitendra Patel, Jean Joseph.
University of Rochester, Rochester, NY, USA.
11:18 a.m.P55.Integrated Safety Results from 4 Randomized, Double-blind, Placebocontrolled Studies of Sipuleucel-T.
Neal D. Shore1, Simon J. Hall2, Paul F. Schellhammer3, Celestia S. Higano4, John M. Corman5, Tomasz M. Beer6, Eric J. Small7, Allan J. Pantuck8, Vahan S. Kassabian9, Frances P. Stewart10, Robert B. Sims10.
1Grand Strand Urology, Myrtle Beach, SC, USA; 2Mount Sinai School of Medicine, New York, NY, USA; 3Eastern Virginia Medical School, Norfolk, VA, USA; 4University of Washington, Seattle, WA, USA; 5Virginia Mason Medical Center, Seattle, WA, USA, 6Oregon Health and Sciences University, Portland, OR, USA; 7University of California, San Francisco, San Francisco, CA, USA; 8University of California, Los Angeles, Los Angeles, CA, USA; 9Georgia Urology, Marietta, GA, USA; 10Dendreon Corporation, Seattle, WA, USA.
11:21 a.m.P56.Therapeutic Value of Lymph Node Dissection at Radical Prostatectomy: A Population-based Retrospective Study.
D. Robert Siemens, Diana Withrow, Julie De Groot, Patti Groome.
Queen’s University, Kingston, ON, Canada.
11:24 a.m.P57.Trans-rectal Ultrasound Volume Estimation: How Much it Can Be Trusted when Choosing the Best Treatment for Localized Prostate Cancer?
Murilo Luz, Simone Chevalier, Armen Aprikian, Alan Dal Pra, Eleonora Scarlata, Lucie Hamel, Fabio Cury.
McGill University, Montreal, QC, Canada.
11:27 a.m.P58.The Natural History and Cause of Death of Men in whom Metastatic Prostate Cancer Developed Following Radical Prostatectomy.
Dan Lewinshtein, Christopher Porter.
Virginia Mason Medical Center, Seattle, WA, USA.
11:30 a.m.P59.Is Post chemotherapy Retroperitoneal Lymphadenectomy Necessary after Complete Response.
Michael Jewett, Jeremy Sturgeon, Lynn Anson-Cartwright, Padraig R. Warde, Mary Gospodarowicz, Malcolm J. Moore.
Princess Margaret Hospital, Toronto, ON, Canada.
11:33 a.m.P60.Outcomes of Patients with Localized Prostate Cancer Treated with Radical Prostatectomy: The Experience of a Single Canadian Institution.
Yasser A. Jamalalail. University of Ottawa, Ottawa, ON, Canada.
11:36 a.m.P61.Comparative Cost-analysis of Roboticassisted Laparoscopic Prostatectomy and Open Prostatectomy.
Jeffrey J. Tomaszewski, Benjamin Davies, Stephen V. Jackman, Ronald L. Hrebinko, Joel B. Nelson.
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
11:39 a.m.Discussion
NoonAdjourn
Noon – 1:30 p.m.Lunch in Exhibit Hall
1:30 – 2:15 p.m.Slotkin Lecture
Irreparable Vesicovaginal Fistulas from Birth Trauma or Sexual Violence in Africa: Difficult Solutions for Desperate Circumstances.
Joseph A. Smith,
Vanderbilt University Medical Center, Nashville, TN
2:15 – 2:30 p.m.Residents Debate
Topic: The Management of Localized Prostate Cancer
2:30 – 3 p.m.Break
3– 4:30 p.m.Concurrent Poster Sessions V & VI
3:35 – 4:30 p.m.Moderated Poster Session V: General Urology and Infertility
Moderators: Julie Franc-Guimond, Ron Benoit
3:35 p.m.P62.Androgen Inducible Genes in Human Prostate Stromal Cells.
Charles Welliver1, Matthew Tanner2, Mengqian Chen2, Michael Shtutman2, Badar Mian1, Ralph Buttyan2.
1Albany Medical Center, Albany, NY, USA; 2Ordway Research Institute, Albany, NY, USA.
3:38 p.m.P63.Role of Pelvic Floor Release (Osteopathic Technique) in the Management of Symptoms Associated with Chronic Non-bacterial Prostatitis (Type III) - A Pilot Study.
Erin Bowser, Kumaresan Ganabathi.
Clarion Hospital, Clarion, PA, USA.
3:41 p.m.P64.Clavien Classification of Surgical Complications Applied to Urological Procedures and Evaluated According to Training Level.
Murilo Luz, Saad Aldousari, Armen Aprikian.
McGill University, Montreal, QC, Canada.
3:44 p.m.P65.Photoselective Vaporization of The Prostate: Technical and Clinical Differences between Potassium Titanyl Phosphate and Lithium Triborate Lasers in Prostates <80 Gm.
Hazem M. Elmansy, Mostafa M. Elhilali.
McGill University, Montreal, QC, Canada.
3:47 p.m.P66.New Sonographically Detected Voiding Urethral Regurgitation may be Initiating Factor in LUTS/CPPS.
Roger E. Vega.
UPMC St. Margaret, Kittanning, PA, USA.
3:50 p.m.P67.Combined Anticholinergic Therapy with Long Term Follow-up in Refractory Overactive Bladder.
Susan J. Marshall, Kevin Pranikoff.
Department of Urology, State University of New York at Buffalo, Erie County Medical Center, Buffalo, NY, USA.
3:53 p.m.P68.Relationship between Prostate Volume and Silodosin-Mediated Improvement of Symptoms Associated with Benign Prostatic Hyperplasia.
Steven A. Kaplan1, Claus Roehrborn2, Lawrence A. Hill3, Weining Volinn3, Gary Hoel3.
1Weill Cornell Medical College, New York, NY, USA; 2UT Southwestern Medical Center, Dallas, TX, USA; 3Watson Laboratories, Salt Lake City, UT, USA.
3:56 p.m.P69.Detection of Vitamin D Deficiency in a General Urology Practice.
Frank J. Costa. Urology Institute of Pittsburgh, Pittsburgh, PA, USA.
3:59 p.m.P70.WITHDRAWN
4:02 p.m.P71.WITHDRAWN
4:05 p.m.P72.Do Urologic Procedures such as Prostate Needle Biopsy and Vasectomy Cause Erectile Dysfunction?
Dan Lewinshtein, Christopher Porter.
Virginia Mason Medical Center, Seattle, WA, USA.
4:08 p.m.P73.WITHDRAWN
4:11 p.m.P74.WITHDRAWN
4:14 p.m.P75.Penile Injury is Apparently not the Underlying Etiology for Peyronie’s Disease in 450 Consecutive Canadian Men: A Single Center Results.
Rany Shamloul, Anthony J. Bella.
University of Ottawa, Ottawa, ON, Canada.
4:17 p.m.P76.Sex, Sexuality and Procreation in Complex Urogenital Anomalies.
Emmanuel O. Abara.
York Central Hospital, Richmond Hill, ON, Canada.
4:20 p.m.Discussion
4:30 p.m.Adjourn
3:35 – 4:30 p.m.Moderated Poster Session VI: Bladder and Penile Cancer
Moderators: Joseph A. Smith, Benjamin Davies
3:35 p.m.P77.Single or Multiple Positive Nodes at Lymphadenectomy Have Similar Cancerspecific Survival in Patients Treated for Penile Squamous Cell Carcinoma.
Rupinder Johal1, Claudio Jeldres1, Giovanni Lughezzani2, Lars Budaus3, Rodolphe Thuret4, Firas Abdollah5, Maxine Sun1, Monica Morgan5, Daniel Liberman5, Salima Ismail5, Al’a Abdo5, Paul Perrotte5, Shahrokh F. Shariat5, Francesco Montorsi6, Pierre I. Karakiewicz1.
1Urology, Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada; 2Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; 3Department of Urology, Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamberg, Germany; 4Department of Urology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France; 5Department of Urology, Cancer Prognostics and Health Outcomes Unit, University of M, Montreal, QC, Canada; 6Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
3:38 p.m.P78.WITHDRAWN
3:41 p.m.P79.Radical Cystectomy for Clinically Muscle Invasive Bladder Cancer: Does Prior Superficial Disease Affect Clinical Outcomes?
Ahmed F. Kotb1, Wassim Kassouf1, Joe Chin2, Yves Fradet3, Jonathan Izawa2, Eric Estey4, Adrian Fairey4, Ricardo Rendon5, Ilias Cagiannos6, Louis Lacombe3, Jean-Baptiste Lattouf7, David Bell5, Darrel Drachenberg8, Armen G. Aprikian1.
1McGill University Health Center, Montreal, QC, Canada; 2University of Western Ontario, London, ON, Canada; 3Laval University, Quebec, QC, Canada; 4University of Alberta, Edmonton, AB, Canada; 5Dalhousie University, Halifax, NS, Canada; 6University of Ottawa, Ottawa, ON, Canada; 7University of Montreal, Montreal, QC, Canada; 8University of Manitoba, Winnipeg, MB, Canada.
3:44 p.m.P80.Survival after Radical Cystectomy of Non-bilharzial Squamous Cell Carcinoma vs. Urothelial Carcinoma: A North American Population-based Study.
Daniel Liberman1, Claudio Jeldres1, Giovanni Lughezzani2, Lars Badaus3, Monica Morgan1, Ala Abdo1, Rupinder Johal1, Maxine Sun1, Shahrokh F. Shariat1, Hugues Widmer1, Paul Perrotte1, Francesco Montorsi2, Markus Graefen3, Pierre I. Karakiewicz1.
1University of Montreal Health Center, Montreal, QC, Canada; 2Vita-Salute San Raffaele, Milan, Italy; 3Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany.
3:47 p.m.P81.Induction of CTL-attracting Chemokines and Local Suppression of Treg-attracting Chemokines in Recurrent Bladder Cancer Requires the Combination of BCG with Interferon-a and Toll-like Receptor Ligands.
Jeffrey Larson, Jeffrey Gingrich, Ravikumar Mathuswamy, Pawel Kalinski.
University of Pittsburgh, Pittsburgh, PA, USA.
3:50 p.m.P82.Defining Morbidity of Robot-assisted Radical Cystectomy Using a Standardized Reporting Methodology.
Matthew H. Hayn, Nicholas J. Hellenthal, Abid Hussain, Andrew Steggman, Khurshid A. Guru.
Roswell Park Cancer Institute, Buffalo, NY, USA.
3:53 p.m.P83.Personalized Management Of Upper Urinary Tract Urothelial Carcinoma: The Effect of Age on Cancer-specific Mortality.
Daniel Liberman1, Monica Morgan1, Rupinder Johal1, Ala Abdo1, Hendrik Isbarn2, Lars Badaus2, Claudio Jeldres1, Giovanni Lughezzani3, Maxine Sun1, Shahrokh F. Shariat1, Paul Perrotte1, Francesco Montorsi3, Markus Graefen2, Pierre I. Karakiewicz1.
1University of Montreal Health Center, Montreal, QC, Canada; 2Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany; 3Vita-Salute San Raffaele, Milan, Italy.
3:56 p.m.P84.The Perioperative Mortality is Significantly Higher in Septuagenarian and Octogenarian Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder.
Daniel Liberman1, Ala Abdo1, Monica Morgan1, Salima Ismail1, Rupinder Johal1, Giovanni Lughezzani1, Lars Badaus2, Hugues Widmer1, Markus Graefen2, Francesco Montorsi3, Shahrokh F. Shariat1, Paul Perrotte1, Pierre I. Karakiewicz1.
1University of Montreal, Montreal, QC, Canada; 2Martini Clinic Prostate Cancer Center, Hamburg-Eppendorf, Germany; 3Vita-Salute San Raffaele, Milan, Italy.
3:59 p.m.P85.Factors Affecting Wait Times for Transurethral
Bladder Cancer Surgery.
Greg Gin, Adam Walker, Barry Kogan.
Albany Medical Center, Albany, NY, USA.
4:02 p.m.P86.Neoadjuvant Chemotherapy as a Predictor of Cost, Readmission and Length of Stay in Radical Cystectomy Patients.
Deep B. Trivedi, Jennifer B. Gordetsky, Guan Wu, Changyong Feng, Susan Messing, Nathaniel Robbins, Thomas Pashalides, Ingrid Mikk, Hani Rashid, Dragan Golijanin, Katia Noyes, Edward Messing.
University of Rochester, Rochester, NY, USA.
4:05 p.m.P87.Continent vs. Incontinent Urinary Diversion after Radical Cystectomy for Urothelial Carcinoma of the Bladder: Comparison of Utilization and Complication Rates.
Monica Morgan1, Rupinder Johal1, Daniel Liberman1, Salima Ismail1, Ala Abdo1, Maxine Sun1, Firas Abdollah2, Giovanni Lughezzani3, Shahrokh F. Shariat2, Paul Perrotte1, Pierre I. Karakiewicz1.
1University of Montreal Health Centre, Montreal, QC, Canada; 2Cancer Prognostics and Health Outcomes Unit, Montreal, QC, Canada; 3Vita-Salute University San Raffaele, Milan, Italy.
4:08 p.m.P88.The Rates of Metastatic Bladder Cancer are Increasing Over Time: A Population-based Analysis.
Monica Morgan1, Rupinder Johal1, Daniel Liberman1, Ala Abdo1, Salima Ismail1, Maxine Sun2, Claudio Jeldres1, Rodolphe Thuret2, Shahrokh F. Shariat2, Lars Budaus2, Markus Graefen3, Paul Perrotte2, Pierre I. Karakiewicz2.
1University of Montreal Health Centre, Montreal, QC, Canada; 2Cancer Prognostics and Health Outcomes Unit, Montreal, QC, Canada; 3Martiniclinic, Prostate Cancer Center University Hospital Hamburg-Eppendorf, Hamburg, Germany.
4:11 p.m.P89.Specificity of Urinary Cytology in the Detection and Surveillance of Bladder Cancer: A Contemporary Analysis and Comparison with Other Urine Markers.
Faysal A. Yafi, Fadi Brimo, Armen G. Aprikian, Simon Tanguay, Manon Auger, Wassim Kassouf.
McGill University, Montreal, QC, Canada.
4:14 p.m.P90.Prostatic Stromal Invasion: A Unique Entity in Patients Treated with Radical Cystectomy for Transitional Cell Carcinoma of the Bladder.
Rupinder Johal1, Daniel Liberman1, Rodolphe Thuret2, Lars Budaus3, Maxine Sun4, Firas Abdollah5, Monica Morgan1, Salima Ismail1, Al’a Abdo1, Claudio Jeldres1, Paul Perrotte1, Shahrokh F. Shariat5, Francesco Montorsi6, Markus Graefen7, Pierre Karakiewicz5.
1University of Montreal Health Center, Dept. of Urology, Montreal, Canada, Montreal, QC, Canada; 2Department of Urology, Montpellier University Hospital, Montpellier, France; 3Department of Urology, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany; 4Cancer Prognosis and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada; 5Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC, Canada; 6Department of Urology, Vita-Salute San Raffaele University, Milan, Italy; 7Department of Urology, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
4:17 p.m.P91.Indocyanine Green (ICG): A Novel Approach to Pelvic Lymph Node Identification in Radical Cystectomy Specimens.
Jennifer Gordetsky, Hani Rashid, Guan Wu, Christopher Silvers, Edward M. Messing, Jorge Yao, Dragan Golijanin
University of Rochester, Rochester, NY, USA.
4:20 p.m.Discussion
4:30 p.m.Adjourn
4:30 – 5:30 p.m.Industry-sponsored Symposium
6:45 – 10 p.m.Fun Night – Pittsburgh Pirates Baseball Game

Saturday, September 25, 2010

7:30 – 8:30 a.m.Annual Business Meeting
7:30 – 8:30 a.m.Residents Breakfast: Public Speaking and Debate
Jim Dutcher, University of Pittsburgh, Pittsburgh, PA
8:30 – 8:45 a.m.Best-of-Poster Session
Presented by moderators of previous day’s poster sessions
8:45 – 9:30 a.m.Plenary VI
NOTES and LESS
Jeffrey Cadeddu, UT Southwestern Medical Center, Dallas, TX
9:30 – 9:45 a.m.Residents Debate
Topic: The Management of a Small Renal Tumor
9:45 – 10 a.m.Break
10 – 10:45 a.m.Plenary VII
Trauma
Richard Santucci, Detroit Medical Center, Detroit, MI
10:45 – 11 a.m.Residents Debate
Topic: The Management of Urethral Stricture Disease
11 – 11:45 a.m.Plenary Session VIII
Evidence-based Medicine as it Relates to Oncology
Badrinath Konety, University of Minnesota, Minneapolis, MN
11:45 – NoonResidents Debate
Topic: The Management of Advanced Prostate Cancer
NoonAdjourn

Articles from Canadian Urological Association Journal are provided here courtesy of Canadian Urological Association